Enovis (NYSE:ENOV) Upgraded to Overweight at Wells Fargo & Company

Wells Fargo & Company upgraded shares of Enovis (NYSE:ENOV – Get Rating) from an equal weight rating to an overweight rating in a report issued on Friday, The Fly reports. The brokerage currently has $67.00 price target on the stock, up from their previous price target of $55.00. Several other equities research analysts have also […]

Related Keywords

Robertw Baird ,Rajiv Vinnakota ,Matthewl Trerotola ,Enovis Corporation ,T Rowe Price Investment Management Inc ,Blackrock Inc ,Dimensional Fund Advisors ,Securities Exchange Commission ,Wells Fargo Company ,Canaccord Genuity Group ,Vanguard Group Inc ,Enovis Company Profile ,Wells Fargo ,Get Rating ,Genuity Group ,Moderate Buy ,Director Rajiv Vinnakota ,Exchange Commission ,Rowe Price Investment Management ,Fund Advisors ,Durable Capital Partners ,Capital Partners ,Enovis Daily ,Genovis ,Nyse Enov ,Senov ,Medical ,Upgrade ,